A Short Communication on Trends of Antithrombotic Treatmentin Atrial Fibrillation Patients Undergoing Percutaneous CoronaryIntervention in GReek-AntiPlatElet Atrial Fibrillation (GRAPE-AF)Registry
Clinical & Experimental Cardiology(2021)
摘要
Patients with Atrial Fibrillation (AF) undergoing percutaneous Coronary Intervention (PCI) represent a high-risk population with an increased ischemic as well as bleeding risk. Aiming to counterbalance thromboembolic risk associated with stent implantation and AF, as well as to mitigate bleeding risk associated with the combination of anthithrombotic drugs, identifying the optimal treatment strategy for this subset of patients remains a challenge in everyday clinical practice [1].
更多查看译文
关键词
atrial fibrillation,percutaneous coronaryintervention,greek-antiplatelet
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要